Carnitines are quaternary amines involved in various cellular processes such as fatty acid uptake, β‐oxidation and glucose metabolism regulation. Due to their neurotrophic activities, their integrative use has been studied in several different physio‐pathological conditions such as anorexia nervosa, chronic fatigue, vascular diseases, Alzheimer’s disease and male infertility. Being metabol-ically active, carnitines have also been proposed to treat reproductive impairment such as functional hypothalamic amenorrhea (FHA) and polycystic ovary syndrome (PCOS) since they improve both hormonal and metabolic parameters modulating the neuroendocrine impairments of FHA. Moreo-ver, they are capable of improving the lipid profile and the insulin sensitivity in patients with PCOS
